Citigroup Inc Nanobiotix S.A. Transaction History
Citigroup Inc
- $163 Billion
- Q4 2024
A detailed history of Citigroup Inc transactions in Nanobiotix S.A. stock. As of the latest transaction made, Citigroup Inc holds 241 shares of NBTX stock, worth $792. This represents 0.0% of its overall portfolio holdings.
Number of Shares
241
Previous 3,423
92.96%
Holding current value
$792
Previous $19,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding NBTX
# of Institutions
18Shares Held
6.25MCall Options Held
0Put Options Held
0-
Johnson & Johnson New Brunswick, NJ5.62MShares$18.5 Million5.5% of portfolio
-
Perceptive Advisors LLC New York, NY266KShares$875,4450.03% of portfolio
-
Black Rock Inc. New York, NY239KShares$786,3360.0% of portfolio
-
Old Mission Capital LLC48.5KShares$159,4790.0% of portfolio
-
Jane Street Group, LLC New York, NY23.3KShares$76,6010.0% of portfolio
About Nanobiotix S.A.
- Ticker NBTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,875,900
- Market Cap $115M
- Description
- Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cance...